Long for a Longtime or until they make me an offer I cant' Refuse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This time is different!
No run up this time....
Shorts are convinced we are going lower.
I believe the Good Doctor may have a surprize for shorty this time.
Too many stars are aligning.
Of course this is just my opinion, but I too have one of those GUT feelings.
got passed the house
Something good is happening...one of the few times a PR is issued without the troll attack... I still think the last PR was a setup to ease some of the Biogen pain when they announce their so so AD results and a partnership with Anavex on or after the conference...
Could this PR been intended for the eyes and ears of Biogen shareholders??? Just asking!
The Good Doctor said "STAY TUNED"
Pipeline expanding making AVXL more attractive to BP... Keep shorting this silly shorts!
http://www.anavex.com/wp-content/uploads/AV-1066-poster-November-2016.pdf
The Bears have overstayed their welcome!
Avxl just what the Good Doctor ordered for Biogen... Keep your fingers crossed that the Biogen study works out ( 70/30 chance my guess). Biogen needs some good news...
George...good to hear from you.
Wouldn't you agree.... The $$$$ offered for a drug that has been proven to work is far greater than one that has not... The Good Doctor has always stated he would not go into phase 3 with a drug that is questionable.
http://www.anavex.com/?news=anavex-receives-notice-of-allowance-for-u-s-patent-application-related-to-anavex-2-73
"This patent is a valuable addition to our IP portfolio and covers innovations we have made in our development efforts for ANAVEX 2-73 and beyond,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.
I read it and from what I read the bottom line was "show me this combination works"
Millstone,
Great to hear from You.
From one old timer to another...Thanks for your input...
"I love it when a plan comes together"
You forgot to Mention the SEC looksee is over.
Some good info on Rett current and past studies. Also another possible funding source.
http://reverserett.org/research/clinical-trials/
That's why they test humans. I did not see a credibility gap.
Just shows the difference between mice and men!
My point was that the more data they are able to mine and analyze the better chance of it being evident the drug is either working or it is not... BTW I see you are getting a bit more bullish.
This is why the company is using cutting edge analytical tools to design and process their P2/3 study
Exercising warrants adds to the float and they can either keep the shares or sell them.
There are still warrants being exercised...
Pleas tell me what the Good Doctor has done wrong and keep in mind his objectives may not be yours.
You have been feeling kind of negative on this company for a long time. I guess I don't understand why you haven't sold and still post.
Man I am jealous, Red Rocks is the best and Jimmy Buffet puts on a great show.
We can agree to disagree....Time will tell.
The Good Doctor has an agenda which may very well be influenced by Biogen.
Keep in mind Biogen needs to sell Anavex to the Market before they make their bid.... I pray for a biding war....
CTAD 2016
8.45 a.m OC59 - 9-Months and 12-Months Safety and Exploratory Efficacy Data of ANAVEX 2-73 in a Phase 2a Study
in Mild-to-Moderate Alzheimer’s Disease Patients
Stephen Macfarlane, MD1, Marco Cecchi, PhD2, Paul Maruff, PhD3 , Kristina M Kapiak4, Christopher U Missling, PhD4
(1) Caulfield Hospital, Melbourne, Australia, (2) Neuronetrix, Louisville, KY, USA, (3) Cogstate Ltd., Melbourne, Australia, (4) Anavex Life Sciences Corp., New York, NY,
USA
Tom I agree.
They will continue to short this till they can't.
I think we are close to some "shortshot" news. JMHO
Could have something to do with their leading edge procedures and methods for testing their drugs.
A daily gap is a gap... I will go with my indicator that has worked 100% of the time I have followed AVXL (4 years).
You know by now the MM's can do what they want with price.
AVXL has always filled the gaps!
What good is a backup plan if you can't use it? This filing just like the update to the lawsuit was based on the SEC decision clearing the company.
It is my understanding that the whole idea of the adaptive trial was to design the phase 3 trial to have the best chance of success. Based on what we have seen so far and the TauRX results, I would think that Phase 3 would have a 273 only arm.
I think the biggest thing is Grant $$$$$.... can you say Retts Phase 2..